Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and Challenges

Area of Science:

• Immunology
• Cancer Biology
• Immunotherapy

Background:

• Natural killer (NK) cells are vital components of the innate immune system, acting as a first line of defense against viral infections and cancer.
• Defects in NK cell development are linked to poorer cancer prognoses, highlighting their role in anti-cancer immune surveillance.
• Preclinical research demonstrates NK cells' capacity to induce tumor regression and prevent relapse, positioning them as promising therapeutic agents.

Purpose of the Study:

• To review the mechanisms by which tumor-intrinsic and -extrinsic factors inhibit NK cell function within the tumor microenvironment.
• To outline current therapeutic strategies aimed at restoring NK cell surveillance in cancer patients.
• To discuss the challenges associated with the clinical application of NK cell-based immunotherapies.

Main Methods:

• This review synthesizes existing literature on NK cell biology and cancer immunology.
• It analyzes preclinical and clinical findings related to NK cell function in cancer.
• The review discusses various approaches to enhance NK cell-mediated anti-cancer immunity.

Main Results:

• Tumor microenvironments often harbor factors that suppress NK cell activity, hindering their anti-cancer potential.
• Strategies exist to overcome these suppressive mechanisms and boost NK cell surveillance.
• NK cells offer a potentially less toxic and more readily available alternative to T cell-based therapies.

Conclusions:

• Restoring NK cell function is a key goal for developing effective cancer immunotherapies.
• Overcoming suppressive tumor microenvironments is critical for successful NK cell-based treatments.
• Further research is needed to address challenges and optimize the clinical use of adoptive NK cell therapies.